ASSESSING THE RISK OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors

  • Atramentova L, A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Kravchun N. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Poltorak V. V. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Gorshunska M. Y. Kharkiv Postgraduate Medical Academy, Kharkiv
  • Jаnsen E. National Institute for Public Health and the Environment, Bilthoven
  • Krasova N. S. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Leshchenko Zh. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Gladkih A. I. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Tyzhnenko T. V. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Plokhotnichenko O. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Opaleiko Y. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Pochernyayev A. K. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Beletskaya O. M. Kharkiv Postgraduate Medical Academy, Kharkiv

DOI:

https://doi.org/10.21856/j-PEP.2015.1.03

Keywords:

retinol-binding protein-4, type 2 diabetes mellitus,nonalcoholic fatty liver disease, logistic regression, ROC-analysis

Abstract

The diagnostic models to highlight the high-risk groups of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus by the level of retinol-binding protein-4, and body mass index using logistic regression and ROC-analysis are developed. By means of logistic regression risk factors for nonalcoholic fatty liver disease are identified. Thresholds predictors of nonalcoholic fatty liver disease are clarified: body mass index of 31 kg/m2 , the concentration of retinol-binding protein-4 — 30 mg/l.

References

Shepherd PR, Kahn BB. N Engl J Med 1999; 341:248-257.

Kahn BB. J Clin Invest 2000; 106:473-481.

Kershaw EE, Flier JS. J Clin Endocrinol Metab 2004; 89:2548-2556.

Yang Q, Graham TE, Mody N, et al. Nature 2005: 436:356-362.

Kostic’ka IO. Ukr Med Zhurn 2010; 4:84-90.

Chen W, Yu Z, Li Y. Zhonghua Gan Zang Bing Za Zhi 2000: 8:76-77.

Marchesini G, Brizi M, Bianchi G, et al. Diabetes 2001; 50:1844-1850.

Sharabi Y, Eldad A. Am J Med 2000; 109:171.

Goritsas C, Spanos K, Stefanopoulos D. Hospital Chronicles 2000: 2(3):100-103.

Babak OJa, Kravchenko NA, Vinogradova SV. Ukr Terapevt Zhurn 2007; 3:98-106.

Komshilova KA, Troshina EA, Butrova SA. Ozhirenie i Metabolizm 2011; 3:3-11.

Wu H, Jia W, Bao Y. Diab Res Clin Pract 2008; 79(2):185-190.

Seo JA, Kim NH, Park SY, et al. Clin Endocrinol 2008; 68:555-560.

Wolf G. Nutr Rev 2007; 65(5):251-256.

Tonjes A, Bluher M, Stumvoll M. Curr Pharm Des 2010; 16(17):1921-1928.

Matthews DR, Hoske JP, Rudensk AS, et al. Diabetologia 1985; 28:412-419.

Katz A, Nambi SS, Mather K, et al. J Clin Endocr Metab 2000; 85:2402-2410.

Fawcett T. ROC Graphs: notes and practical considerations for data mining researchers, Netherlands, 2004:1-38.

Halafjan AA. STATISTICA 6. Statisticheskij analiz dannyh, Moskva, 2007: 512 p.

Banerdzhi A. Medicinskaja statistika ponjatnym jazykom, Moskva, 2007: 288 p.

Metz CE. Fundamental ROC analysis: Handbook of Medical Imaging: Physics and Psychophysics, Bellingham WA, 2000; 1:754-769.

Fajnzil’berg LS, Zhuk TN. Upravljajushhie Sistemy i Mashiny 2009; 5:3-13.

Van den Hout WB. Med Decis Making 2003; 23:160-166.

Schlisterman EF, Perkins NJ, Liu A, et al. Epidemiology 2005; 16:73-81.

Downloads

Published

2021-06-23

How to Cite

Atramentova, L. A., Kravchun, N. A., Poltorak, V. V., Gorshunska, M. Y., Jаnsen E., Krasova, N. S., Leshchenko, Z. A., Gladkih, A. I., Tyzhnenko, T. V., Plokhotnichenko, O. A., Opaleiko, Y. A., Pochernyayev, A. K., & Beletskaya, O. M. (2021). ASSESSING THE RISK OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS . Problems of Endocrine Pathology, 51(1), 21-27. https://doi.org/10.21856/j-PEP.2015.1.03

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

1 2 3 4 5 > >>